At Koneksa, we partner with leading research and philanthropic foundations to push the envelope of clinical research methodology and find treatments that don’t currently exist. We also partner with leading technology and diagnostic companies to give our clients access to the best patient-centric solutions for their studies.
We believe that you don’t have to solve every technical problem yourself, and we practice what we preach. We work with partners who are leading in their areas to provide the best possible trial experience for all stakeholders.
Foundations
We are a leader in supporting clinical studies for neurological disorders. Through our partnership with The Michael J. Fox Foundation for Parkinson’s Research, we have received two grants to advance the use of digital biomarkers in Parkinson’s disease research: Koneksa is working with Northwestern University to investigate speech symptoms, and we are using digital measures to evaluate disease progression.
Technology and Diagnostic Partnerships
Koneksa has a long-standing partnership with Uscom, the manufacturer of the industry-leading SpiroSonic AIR ultrasonic mobile spirometer. Uscom and Koneksa’s scientific and technical leadership has worked extensively together to enhance Koneksa’s technology, resulting in the deployment of Uscom’s novel SpiroSonic spirometers and software across a variety of clinical studies around the globe that require precision pulmonary monitoring.
Koneksa has also recently joined a close partnership with Aural Analytics to strengthen our platform with speech analysis capabilities. Speech characteristics can be a key indicator of disease progression and patient health status, particularly in neurodegenerative diseases. We are excited to integrate these advanced capabilities into our remote clinical trial solutions.
Koneksa has partnered with TechEd Consultants, Inc., a global leader in pulmonary function testing. In addition to joint services supporting our customers’ clinical trials, TechEd supports Koneksa’s internal development efforts to improve our core offerings and expand the range of respiratory measures we can deploy.
We also work with a variety of other device and assessment providers to create and deploy enhanced and composite measures for a one-stop digital biomarker solution.